Cf trials23 Jan 2018 09:49
First patient enrolled in papworth Cambridge clinical trial 4th April 20177 on 52 day trial start to finish according to report.Apparently last edited September 2015. Co- incide�tally a few weeks after end of September the share price started to drop so one could summise that the trials at papworth may not have shown clinically significant data re cf patients. According to article a grant of �100k was used from cf organisational �200k was invested by Verona Pharma into the trial. I would have presumed that all data for this would have been collated and analysed by sept of 2017. The fact that we have had no announcements from the company some further 4 months on does not appear to positive IMO and probably explains SP drop back end of last year. For all the seriously invested lth's on this board I hope not. If those require more articles type in clinical cf trials papworth rpl554. Izstar, dgger01, spot, BH and bewise good luck on your investments and good health to all for this year